Last update: 2/07/26
Connect with us:



ABSTRACT BOOK - WAY TO GALA DINNER
abstract submission only for Poster presentation are still possible
some British Pharmacological Society travel grants and Poster awards (Ambiotis, ESLM) are still available
30 hotel rooms at a preferential rate are available at the International University Campus of Paris

Co-organized with the

Welcome

Scientific Program

Young Investigator Symposium, Poster Awards and Travel Support

Registration & Abstract Submission

All the sponsors

Venue Photos-Map

Travel Informationn

Hotel Reservation

Committees and Contact

Past-Workshops on Lipid Mediators

Our Gold and Major Sponsors:




All the Sponsors


Program

PROGRAM
16 Invited speakers + 31 Talks selected from the submitted abstracts

Wednesday, July 1st (Duclaux amphitheater)
8:15 Registration with refreshments

8:50 – 10EWLM Welcome address by Gerard Bannenberg and Xavier Norel

Educational SESSION: Control at the Source in Lipid Biology

9:00 – Opening address by chairpersons: Valérie Urbach and Per-Johan Jakobsson

9:05 - 9:30 – Thierry Durand - 1IBMM, CNRS, France (25 min)
How to analyse NEO-PUFAs and Natural Lipophenols: Thanks to LC-MS/MS and Targeted Lipidomics

9:30 - 9:55 - Beatrix Suess - Technical University of Darmstadt, Germany (25 min)
RNA-based control at the site of signal generation

9:55 - 10:20 Dieter Steinhilber - Goethe University Frankfurt, Germany (25 min)
MicroRNA regulation at the origin of lipid mediator synthesis

COFFEE BREAK (Modules, and Sponsor stands visit) 10:20 - 10h45

 

 1st Sponsored SESSION: Lipid mediator analytics and biomarkers

10:45 - Welcome by chairpersons: Gijs Kooij and Marc Dubourdeau

10:50 – 11:15 - Laura Bindila* - Medical University Mainz, Germany (25 min)
4D Lipidomics for cellular and circulatory phenotyping with diseases

11:15 – 11:40 - Ingela Lanekoff* - Uppsala University, Sweden (25 min)
Mapping the distribution of lipid mediators in tissue

11:40 – 12:40 - Selected speakers (3x 20 min incl Q&A)

Negar Mir - University of Toronto, Canada
Species-Level Biomarkers of MASLD and MASH Progression in Normolipidemic Individuals with Obesity

Serhii Chornyi - Vrije Universiteit Amsterdam & Leiden University Medical Centre, The Netherlands
Profile and origin of lipid mediators in pneumococcal meningitis

Marta Reina-Couto - Univerity of Porto, Portugal
Multimarker profiling of inflammatory and resolution mediators to differentiate septic from cardiogenic shocks

 

LUNCH BREAK 12:40 - 14:25 (Modules, and Sponsor stands visit)

 

2nd Sponsored SESSION: Analytical challenges and clinical applications of oxylipins

The Lipidomics Research and Study Group (GERLI

14:25 - Welcome by chairpersons: Cécile Gladine and Thierry Durand

14.30 – 14.55 - Denise Biagini* - University of Pisa, Italy (25 min)
Unlocking oxylipin and PUFA profiling in unconventional biofluids:
Challenges, pitfalls, and clinical potential

14.55 – 15.20 - Craig Wheelock*- Karolinska Institutet, Stockholm, Sweden (25 min)
Targeted Spatial Metabolomics for Mapping Lipid Mediator-Related Inflammation in the Lung

15:20 – 16:20 - Selected speakers (3 x 20 min incl Q&A)

Jean-Marie Galano - IBMM Montpelier, France
Trioxilins Are Back: Rediscovering Overlooked Oxylipin Chemistry

Carlos R. Canez - University of Alberta, Canada
When Contaminants Masquerade as Lipids: Building a Contaminant Library to Prevent Misannotations in Lipidomics

Jose Luis Moreno-Casillas - Health Research Institute La Fe (IIS La Fe), Valencia, Spain
Comparative evaluation of microsampling devices for oxylipin analysis in newborn blood

(+10 min) Award ceremony "GREMI Thesis Prize - Michel CHIGNARD"
Laureate 2025: Alberto IANNUZZO

 

 18:00 OPENING RECEPTION (CIS Building)

------------------------------------------------------------------------------------------------

Thursday, July 2nd (CIS Building)
8:00 Registration with refreshments
8:50 – Welcome address by Gerard Bannenberg & Xavier Norel

9:00 - 9:40 Opening Plenary Lecture, chair person: Xavier Norel

Nan Chiang*- Brigham and Women's Hospital and Harvard Medical School, Boston, USA
Specialized Pro-resolving Mediator Pathways and Receptors In Orchestrating Resolution and Regeneration.


COFFEE BREAK (+ poster viewing, and Sponsor stands visit, CIS Building) 9:40 - 10:40


SESSION 1: Lipid mediators in Infection, inflammation and immunity 10:40 -12:15

10:40 - Welcome by chairpersons: Valérie Urbach & Adriano Rossi

10:45 - 11:10 Julia Esser-von Bieren* - University of Lausanne, Switzerland
Role of macrophage-derived prostanoids in helminth infection

11:10 – 11:35 Martin Giera* - Leiden University Medical Center, Leiden, Netherlands
Lipid Mediator, Not Lipid Mediator: Redefining Bioactive Lipids Beyond Oxylipins

11:35 – 12.14 Selected speakers (3x13 min incl Q&A)

11:35 – 11.48
Jerome Hendriks
- Univeristy of Hasselt, Belgium
Loss of CD36 induces disease-associated OPCs in the brain via pro-inflammatory eicosanoid signaling impairing remyelination

11:48 – 12.01 Stephania Libreros - Yale School of Medicine, USA
Cracking the Lipid Mediator Code of Septic Neutrophils

12:01 – 12.14 Helena Fisk - University of Southampton, UK
EPA+DHA and their monohydroxy-oxylipin metabolites increase mitochondrial respiration capacity in M0 but not M1 macrophages

LUNCH BREAK 12:15 - 13:45 (CIS Building)



SESSION 2: Lipid mediator chemistry and molecular biology 13:45 -15:10

Welcome by chairpersons: Gijs Kooij & Chengcan Yao

13:50 - 14:15 - Derek J. Taylor* - Case Western Reserve University, Cleveland, USA
Structures of inhibitor-bound 15-PGDH:
insights into molecular mechanisms and regenerative therapeutic opportunities

14:15 - 14:40Jesmond Dalli* - William Harvey Research Institute - Queen Mary University of London, UK
Decoding resolution biology:
New insights into molecular dysregulation driving disease progression

14:40 – 15.06 Selected speakers (2x13 min incl Q&A)

14:40 – 14.53 Robert Hofstetter - University Jena, Germany
Functional lipid mediator screening identifies prostaglandin D2 as suppressor of mPGES-1 expression via the Keap1-Nrf2 axis in macrophages

14:53 – 15.06 Christoph Matti - University College London, UK
Novel LysoPS GPCR Signalling in B Cell Responses

COFFEE BREAK (+ poster viewing, and Sponsor stands visit, CIS Building) 15:10 - 16:10


YOUNG INVESTIGATOR SESSION 16:10 - 17:30

Chair persons: Mireille Alhouayek & Gerard Bannenberg
10 Talks selected from the submitted abstracts
(6 + 2 min Q&A each, timed)

SHORT BREAK (10-15 min)

 

SESSION 3: Lipid mediators in cancer biology 17:45 - 19:10

Welcome by chairpersons: Cristina López-Vicario & Per-Johan Jakobsson

17:50 - 18:15 - Paola Patrignani* - G. d'Annunzio" University Medical School, Chieti, Italy
The crucial role of platelet eicosanoids in cancer:
An opportunity to prevent cancer development and metastasis
through targeted therapeutic interventions

18:15 – 18.40 - Anna Martling*- Karolinska Institutet & University Hospital, Stockholm, Sweden
Low-Dose Aspirin for Secondary Prevention in Colorectal Cancer:
Results from the Nordic ALASCCA Trial

- A 50% Reduction in Recurrence in Genetically Selected Patients

18:40 – 19:06 Selected speakers (2x13 min incl Q&A)

18:40 – 18.53 Karin Larsson - Karolinska Institutet & University Hospital, Stockholm, Sweden
Relieving Prostaglandin-Mediated Immunosuppression Unlocks Neoantigen Vaccine Efficacy

18:53 – 19.06 Emiko Yoda - Showa Medical University, Japan
Role of mPGES-1 in irinotecan-induced gastrointestinal toxicity

 

20:00 GALA DINNER (Cruise on Seine River)

----------------------------------------------------------------------------------------------

Friday, July 3rd (CIS Building)
8:15 Registration with refreshments
09:00 - 09:05 – Morning address by Giulio Muccioli

09:05 - 09:45 Second Plenary lecture, Chair person: Giulio Muccioli

Vincenzo Di Marzo* - ICB-CNR, Pozzuoli, Italy / Université Laval, Québec City, Canada
The endocannabinoidome, the gut microbiome and dietary fatty acids:
a well functioning triangle.

COFFEE BREAK (+ poster viewing, and Sponsor stands visit, CIS Building) 9:45 - 10:45

 

 

SESSION 4: Dietary lipids and supplements 10:45 - 12:05

Welcome by chairpersons: Chengcan Yao & Marc Dubourdeau

10:50 - 11:15 - Robert Caesar* - University of Gothenburg, Sweden
Interaction between lipids and gut microbiota influences metabolic health

11:15 - 11:40 - Regina Rodrigo* - Principe Felipe Research Center (CIPF), Valencia, Spain
Inflammation resolution in retinal degeneration:
The emerging role of specialized pro-resolving lipid mediators in hereditary retinal diseases

11:40 – 12:06 Selected speakers (2x13 min incl Q&A)

11:40 – 11.53 Maria Jose Ruiz-Pastor - Murcia Institute of Biomedical Research (IMIB), Spain
Beyond DHA: Key Fatty Acids Driving Retinal Degeneration and Their Implications for Nutritional Therapies

11:53 – 12.06 Simin Zhang - Karolinska Institutet, Sweden
Low dose n-3 PUFA supplementation shifts plasma oxylipins from AA- to EPA-derived pathways: a sub-study of the GISSI-Prevenzione trial

LUNCH BREAK 12:06 - 13:40 (CIS Building)

 

3rd Sponsored SESSION on Resolution of Inflammation 13:40 - 15:10

COST EU RESOLVE

Welcome by chairpersons: Véronique Witko & Oliver Werz

13:40 – 14:20 “Introducing the COST-EU-Resolve”

Speakers: Jesmond Dalli, Cristina Lopez, Denise Biagini and Joan Clària.

(Overview, activities of WG1-6, options for young researchers, Q&A)

14:20 – 15:10 “Concepts of inflammation resolution”

Mauro Perretti* (20+5 min): Resolution of Inflammation; state-of-the-art and translational landscape

Ana Maria Briones* (20+5 min): Role of specialized proresolving mediators in cardiovascular damage in hypertension

COFFEE BREAK (+ poster viewing, and Sponsor stands visit, CIS Building) 15:10 - 15:40

 

 

SESSION 5: Lipid mediators in cardiovascular and metabolic diseases 15:40 – 17:15

Welcome by chairpersons: Xavier Norel & Giulio Muccioli

15:45 - 16:10 - Philippe Gabriel Steg* - Bichat Hospital, INSERM U1148, Paris, France
Clinical trials of omega 3 fatty acids for cardiovascular prevention

16:10 - 16:35 - Magnus Bäck* - Karolinska Institutet & University Hospital, Stockholm, Sweden; INSERM U1116, Nancy, France
Resolving cardiovascular inflammation through omega-3-derived lipid mediators

16:35– 17:14 Selected speakers (3x13 min incl Q&A)

16:35 – 16:48 Sven-Christian Pawelzik - Karolinska University Hospital Solna, Sweden
Prostacyclin is an endogenous protection against aortic stenosis progression and aortic valve prosthesis deterioration

16:48 – 17:01 Frances Yen - INSERM U1116, University of Lorraine, France
Increased lipid dyshomeostasis in metabolic syndrome due to deletion of resolvin D2 receptor GPR18 in mice

17:01 – 17:14 Nathalie Mercier - Université de Lorraine, Inserm U1116, France
Deletion of GPR18 in mice leads to altered vascular mechanical properties

 

 17:15 - Prize Winners and travel support announcements (Young session awards, Poster Prizes,etc)

17.30 - Adjourn: Workshop closing address by Xavier Norel & host for 11th EWLM

* indicates invited speaker

 

 

Printable A4 Program



Sponsored sessions by

Our Gold and Major Sponsors: